View in EDS

Monitoring of measurable residual disease by next‐generation sequencing in patients with acute myeloid leukaemia.

Saved in:
Bibliographic Details
Title: Monitoring of measurable residual disease by next‐generation sequencing in patients with acute myeloid leukaemia.
Authors: Boudry, Augustin1,2 (AUTHOR), Goursaud, Laure3,4 (AUTHOR), Lebon, Delphine5,6 (AUTHOR), Dumezy, Florent1 (AUTHOR), Harrivel, Véronique7 (AUTHOR), Boue‐Raguet, Alexandre5 (AUTHOR), Joudinaud, Romane1,4 (AUTHOR), Marceau‐Renaut, Alice1,4 (AUTHOR), Geffroy, Sandrine1,4 (AUTHOR), Hauspie, Carine1 (AUTHOR), Brijs, Jan3,4 (AUTHOR), Fenwarth, Laurène1,4 (AUTHOR), Berthon, Céline3,4 (AUTHOR), Marolleau, Jean‐Pierre5,6 (AUTHOR), Figeac, Martin8 (AUTHOR), Preudhomme, Claude1,4 (AUTHOR), Duployez, Nicolas1,4 (AUTHOR) nicolas.duployez@chu‐lille.fr
Source: British Journal of Haematology. Nov2025, Vol. 207 Issue 5, p1953-1961. 9p.
Database: Academic Search Ultimate
Description
ISSN:00071048
DOI:10.1111/bjh.70135